Log in to save to my catalogue

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2986553

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

About this item

Full title

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

Publisher

Cham: Springer International Publishing

Journal title

European journal of human genetics : EJHG, 2009-08, Vol.17 (8), p.991-998

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Thiopurine
S
-methyltransferase (TPMT) is the rate-limiting step in the conversion of thiopurine drugs including azathioprine (AZA) to inactive metabolites. Heritable deficiency of TPMT activity increases risk for adverse events, most notably, myelosuppression leading to leukopenia and neutropenic sepsis. The reported European Commission stud...

Alternative Titles

Full title

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2986553

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2986553

Other Identifiers

ISSN

1018-4813

E-ISSN

1476-5438

DOI

10.1038/ejhg.2009.10

How to access this item